SCHEMBL14083880

SCHEMBL14083880

CCOC(=O)c1cccc(NC(=O)c2ccc(-c3ncccc3Cl)cc2)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 8/20 0.60
▸ NPC1 O15118 6/20 0.60
▸ MAPT P10636 5/20 0.60
▸ SMN1; SMN2 Q16637 4/20 0.60
▸ ALDH1A1 P00352 4/20 0.60
▸ MAPK1 P28482 2/20 0.60
▸ LMNA P02545 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ TRPV1 Q8NER1 4/20 0.59
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ ABCB1 P08183 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ ABCG2 Q9UNQ0 1/20 0.55
▸ POLB P06746 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ CYP1A2 P05177 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083992 0.90 RAB9A (0.63) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14083861 0.89 TRPV1 (0.70) RAB9ANPC1MAPTSMN1; SMN2TRPV1
SCHEMBL14083705 0.86 RAB9A (0.54) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14083818 0.86 MAPT (0.55) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14083920 0.86 TRPV1 (0.60) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14083872 0.85 TRPV1 (0.63) RAB9ANPC1SMN1; SMN2TRPV1MEN1
SCHEMBL3885110 0.85 TRPV1 (0.66) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL14083475 0.82 TRPV1 (0.65) RAB9ANPC1MAPTSMN1; SMN2TRPV1
SCHEMBL28007798 0.82 RAB9A (0.73) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14083465 0.82 TRPV1 (0.63) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 RAB9A 1914/4885NPC1 1061/4885MAPT 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback